The Medical Device Patient Safety Act includes a requirement that the Food and Drug Administration assess device recalls, determine whether a recall was implemented effectively and terminate the recall once completed.
In addition, this legislation would allow the FDA to require collection of post-market data as a condition of approval and rescind a device’s pre-market approval if the medical device company did not perform post-market studies as required.
Related Articles on Medical Device Safety:
AAMI Releases Report on Medical Device Reprocessing
10 Things Healthcare Providers Can Do Now to Improve Alarm Conditions
FDA Orders Device Makers to Review Risks of Implantable Surgical Mesh
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
